Skip to search formSkip to main contentSkip to account menu

FC-1271a

Known as: FC-1271 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Ospemifene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Ospemifene in the Treatment of Vulvovaginal Atrophy
Objective: To review the pharmacology, efficacy, and safety of ospemifene in the management of dyspareunia. Data Sources… 
2004
2004
Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene
Tamoxifen has been used for the treatment of breast cancer since the 1970s, but is considered a carcinogen because it has been… 
Highly Cited
2002
Highly Cited
2002
Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women.
Highly Cited
2001
Highly Cited
2001
In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer
2000
2000
Pharmacokinetics of (deaminohydroxy)toremifene in humans: a new, selective estrogen-receptor modulator
AbstractPurpose: New selective estrogen-receptor modulators for the treatment and prevention of osteoporosis, cardiovascular… 
1999
1999
Quantitative analysis of Z-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol in human plasma using high-performance liquid chromatography.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)